LMR was found to be a prognostic factor in small cell lung cancer [22], in early-stage NSCLC patients post operation [23], in advanced lung cancer treated with cytotoxic chemotherapies [24], and in EGFR-mutant lung cancer patients treated with first-line EGFR-TKIs [14]. This evidence concerns the gene EGFR and lung carcinoma.